Parkwalk Advisors

Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.

Cambridge GaN Devices develops gallium nitride based power devices and transistors designed to improve energy efficiency in power electronics. The company designs, creates, and commercializes GaN-based semiconductors that achieve faster switching, lower energy losses, and smaller form factors compared with traditional silicon devices while delivering higher power density. Its products are intended for applications in sectors such as renewable energy, electric vehicles, and consumer electronics, enabling compact and more efficient power conversion and energy management. The company collaborates with industry partners to drive innovation and accelerate adoption of GaN technology in the power semiconductor market.

Illumion is a technology company specializing in energy storage solutions. It develops and manufactures a lab-based, real-time measurement device that provides detailed insights into energy storage processes at sub-micrometer scales. This device enables researchers to visualize and understand energy storage processes in real-time, optimize material usage, and identify performance limitations at the microscopic level, thereby accelerating battery development and enhancing energy storage efficiency and performance.

Founded in 2011, PervasID specializes in developing wide area RFID systems that offer location capabilities based on the EPC Class1 Gen2 standard. The company's technology enables accurate tracking of goods and assets across various industries.

DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.

Ikarovec is a gene therapy company focused on developing early-stage treatments for common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, working on therapies that also target dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By advancing these innovative treatments, Ikarovec seeks to provide effective solutions for patients, helping to restore sight and prevent blindness.

Evoralis is a company specializing in the discovery and development of enzymes that can break down plastic waste. It was founded as a spin-out from the University of Cambridge.

PhoreMost is a UK-based drug discovery company specializing in identifying new druggable targets for cancer and other diseases. Established in 2014, it develops Site-Seeker, a platform that systematically uncovers druggable sites in the human genome and links them to useful therapeutic functions in live cells.

OW Smell Made Digital specializes in developing software and hardware solutions for controlling and integrating digital smell technology into various products, services, or content.

Xwatts is a developer of an intelligent energy management system specifically designed for commercial buildings. The company focuses on reducing costs and emissions through continuous analysis of energy usage patterns, environmental conditions, and market data. By optimizing and automating electricity consumption, Xwatts enables building owners to take direct control of their distributed energy assets. The system evaluates historical usage alongside real-time market data to enhance asset scheduling and minimize electricity consumption costs, thereby promoting more efficient energy management in commercial properties.

Psyomics specializes in the development of proteomic diagnostics aimed at improving early diagnosis and treatment outcomes for individuals with neuropsychiatric disorders. The company offers web-based assessment triage designed to facilitate diagnostic and pathway prediction for mental health conditions. By integrating digital profiling with cutting-edge biological research, Psyomics enhances diagnostic accuracy and supports primary care practitioners in effectively managing their patients' mental health needs. This innovative approach digitally replicates a psychiatric assessment at the initial point of contact, thereby enabling patients to achieve better recovery outcomes from mental health disorders.

Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.

Adsilico is a medical technology company that specializes in developing advanced computer simulations to assess the safety and performance of medical devices. By using virtual patients, the company helps clients identify potential issues early in the development process, expedite time to market, and reduce the costs associated with traditional clinical trials.

Echopoint Medical Ltd, established in 2018 and headquartered in London, specializes in developing medical devices that incorporate optical-fibre based sensors. The company leverages optical fibre sensing technologies to enhance precision and efficacy in invasive cardiology and other minimally invasive procedures, with a focus on transforming the diagnosis and treatment of cardiovascular diseases.

MeVitae develops a talent intelligence platform that promotes fair hiring practices. It uses anonymized CV screening and ethical AI-driven decision-making, integrating seamlessly with HR systems to enable inclusive hiring for enterprise and public sector organizations.

Koalaa specializes in the development of soft prosthetic arms and personalized support solutions for individuals of all ages, including babies, children, and adults. The company aims to enhance the quality of life for its users by providing comfortable and affordable prosthetic options. Its innovative slip-on-and-go prosthetic arm features a soft fabric construction and interchangeable tools, making it lightweight and user-friendly. This design allows wearers to perform everyday tasks with ease while ensuring comfort throughout the day. Koalaa is committed to making its prosthetic products accessible to anyone in need, reinforcing its mission to improve lifestyles through functional and adaptable solutions.

Founded in 2019, Wayland Additive specializes in developing, manufacturing, and distributing metal additive manufacturing 3D printing machines. The company serves industries such as aerospace and medical, offering advanced solutions like electron beam lithography.

Albus Health is a startup spun out from the University of Oxford. It has developed an intelligent nocturnal monitoring platform that offers personalized, passive, contactless, and objective monitoring of various symptoms and environmental metrics at home. The platform has been commercialized and is currently used by leading pharmaceutical companies to monitor nocturnal symptoms in clinical trials, with the potential to predict respiratory emergencies.

Proxisense specializes in developing proximity sensors and fluid contamination monitoring systems using eddy current technology. Their real-time turbine blade health monitoring systems extend component lifetimes and reduce maintenance costs, targeting the power and aerospace industries. They also provide reliable fluid monitoring to prevent damage and optimize operating conditions for transportation assets.

Nu Quantum Ltd is a company focused on developing quantum photonics hardware and quantum networking infrastructure to enhance the capabilities of quantum computing. Established in 2018 and based in Cambridge, United Kingdom, the company specializes in creating photon sources, detectors, and systems for quantum cryptography. Nu Quantum's innovations include nano-engineered materials for the generation of light at the quantum level and ultra-sensitive light detection systems. The company aims to establish the necessary infrastructure for interconnecting quantum computing cores into large distributed clusters, which is essential for scaling quantum computers. By developing full hardware solutions, including high-speed network interfaces and photonic switching fabrics, Nu Quantum seeks to facilitate the creation of entangled qubit networks. The company collaborates with leading quantum computing firms, governments, and research institutions to bring its advanced technologies to market, focusing on secure cryptographic key exchange and the future of information processing.

Mogrify develops proprietary platform technologies that enable direct cellular reprogramming. These platforms use big-data approaches to predict transcription factors and growth factors required for producing any target human cell type from any source human cell type. Mogrify applies these platforms to generate functional cell types for in vivo reprogramming therapies, focusing on ophthalmology, otology, metabolic diseases, and other degenerative conditions.

Fresh Check is a simple sticker that you put inside the packaging of food that changes colour when your food has actually gone off, not when the use-by date says so.

Phasecraft is a UK-based company founded in 2018 by world-class quantum scientists and engineers. They specialize in developing quantum software for intermediate-scale devices and quantum computers, aiming to accelerate practical applications of quantum computing.

Entia specializes in improving access to blood tests through innovative medical devices. Founded in 2014, it offers Aptus for haemoglobin and haematocrit testing, benefiting health screening, maternal care, nutrition, and sports fields. Additionally, Entia provides Affinity, enabling cancer patients to monitor their blood counts at home, reducing infection risks and hospital visits.

RoboK develops innovative computer vision technology to enhance safety and efficiency in industrial workplaces. Founded in 2017, the company transforms on-site visual data from CCTV cameras into valuable actionable insights for critical infrastructure operators.

Cambridge Touch Technologies develops piezoelectric-based 3D touch technology for smartphones, tablets, automotive, and industrial applications. Its UltraTouch platform combines proprietary artificial intelligence with sophisticated signal processing and a piezoelectric force film to deliver an all-in-one touch and force sensor architecture that offers advanced functionality at lower cost and scales to curved and foldable device sizes. The company targets pressure sensing and 3D touch to enhance interaction in consumer electronics and industrial applications.

Signaloid is a technology company that specializes in computing platforms and software solutions aimed at uncertainty-tracking in data inputs. Its offerings include a cloud platform and application programming interface that facilitate advanced computations and data storage. The company's technologies are applicable across various fields such as materials modeling, autonomous systems, computational finance, machine learning, and quantum computing. By leveraging its innovations, Signaloid enables clients to assess the impact of uncertainties on their decision-making processes, helping them to ensure compliance with regulations, optimize costs, and enhance safety outcomes.

PharmEnable Limited is a drug discovery company based in Cambridge, United Kingdom, that specializes in the design of small molecule drugs through the integration of medicinal chemistry and artificial intelligence computational methods. Established in 2016, the company has created a rapid and cost-effective approach to identify superior chemical starting points, thereby facilitating the discovery of essential new medicines.

DefiniGEN specializes in providing human cell products for life science and drug discovery sectors. Its offerings include specialized hepatocytes and pancreatic cells for predictive toxicology, diabetes research, and disease modeling. The company serves pharmaceutical companies by offering custom cell production services and contract services such as Def-PANC diabetes compound profiling.

Carbometrics is a specialist chemistry company focused on the design, synthesis and derivatisation of highly selective carbohydrate-binding molecules. Its technology centers on glucose-binding receptors developed for sensing applications, produced through a scalable synthesis that delivers robustness under demanding conditions. Building on more than 20 years of research from Professor Anthony Davis’s group at the University of Bristol, the company aims to realise a reliable glucose sensing platform for healthcare use, including continuous glucose monitoring. The approach seeks to enable accurate, robust detection of glucose in diverse environments, supporting the development of next-generation glucose sensors.

Founded in 2018, Xampla develops plant-based materials derived from pea protein to replace microplastics. Its product range includes microcapsules for homecare and personal care products, films, coatings, and single-use plastics for packaging applications.

Founded in 2019, Wayland Additive specializes in developing, manufacturing, and distributing metal additive manufacturing 3D printing machines. The company serves industries such as aerospace and medical, offering advanced solutions like electron beam lithography.

AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.

OSSTEC specializes in advanced orthopedic implants, focusing on knee replacement surgeries. Its metal 3D printed implants mimic natural bone structure, reducing stress shielding, promoting bone ingrowth, and enhancing long-term implant stability for patients with osteoarthritis.

LettUs Grow develops aeroponic irrigation and farm management technology for greenhouse and vertical farming. The company designs modular, nozzle-free aeroponic systems that deliver nutrient mist to plant roots and are paired with automated control software to optimize conditions for individual species, while enabling pesticide-free operation. Its hardware and software aim to reduce labor, improve efficiency, and lower costs, with environmental benefits such as reduced waste and carbon footprint. Founded in 2015 and based in Bristol, United Kingdom, LettUs Grow markets solutions that support sustainable indoor farming.

TextMine is an AI-powered knowledge base that consolidates business-critical documents such as invoices, payslips, tender documents, compliance reports, and contracts into a single operational layer. This enables proactive decision-making, increases data transparency, and allows for more scalable and uniform document creation, ultimately helping organizations save time and money while reducing risk and enhancing compliance.

NoBACZ develops a precision bandage technology for human and veterinary wound care. The platform creates rapid-set liquid barriers that act as sterile, antimicrobial, and biodegradable coverings. It can be tailored to a variety of wound types, enabling clinicians to quickly treat deep wounds in medical settings and in veterinary and farm environments, while reducing the risk of infection associated with traditional bandages.

Mind Foundry Limited, incorporated in 2015 and based in Oxford, United Kingdom, develops enterprise software that enables organizations to extract valuable insights from their data. As an Oxford University company founded by leading experts in artificial intelligence and machine learning, Mind Foundry focuses on creating Responsible AI solutions designed to address significant real-world challenges across various sectors, including insurance, infrastructure, and defense. Their AI platform leverages advanced machine learning and algorithmic modeling techniques to help organizations tackle issues such as insurance fraud detection and complex signal processing. By promoting the responsible and transparent use of AI, Mind Foundry aims to foster collaboration between humans and artificial intelligence to address pressing global problems.

Zomp is a provider of consumer electronics.

Symetrica Ltd. is a company that specializes in the development and commercialization of integrated radiation detection and identification technologies. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, Symetrica serves various sectors including military, homeland security, medical diagnostics, geophysical, and space research. The company produces a range of advanced devices, such as handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, which utilize machine learning to enhance operational effectiveness for security teams. These systems are employed by customs and border protection, law enforcement, military, and emergency services around the world, enabling them to identify threats and respond efficiently.

Quantum Motion Technologies is developing a universal quantum computer using Silicon-based CMOS processes. Its focus lies in creating scalable arrays of qubits, aiming to develop quantum computing architectures compatible with existing silicon processing methods.

Founded in 2016, Qkine is a biotechnology company based in Cambridge, UK. It specializes in manufacturing high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell culture, organoid research, and regenerative medicine.

DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.

Cambridge GaN Devices develops gallium nitride based power devices and transistors designed to improve energy efficiency in power electronics. The company designs, creates, and commercializes GaN-based semiconductors that achieve faster switching, lower energy losses, and smaller form factors compared with traditional silicon devices while delivering higher power density. Its products are intended for applications in sectors such as renewable energy, electric vehicles, and consumer electronics, enabling compact and more efficient power conversion and energy management. The company collaborates with industry partners to drive innovation and accelerate adoption of GaN technology in the power semiconductor market.

Enhanc3D Genomics is a biotechnology firm focused on functional genomics, specifically examining the three-dimensional organization of DNA and its implications in health and disease. The company has developed the GenLink3D platform, which facilitates large-scale analysis of genetic variations and gene function by providing high-resolution profiles of genome folding for all genes and their enhancers simultaneously. This innovative technology enables researchers to understand the impact of genetic mutations on distant genes, thereby elucidating their role in disease progression. By advancing knowledge in this area, Enhanc3D Genomics supports the development of novel drug therapies aimed at addressing significant unmet medical needs.

Opsydia Limited, established in 2017 and based in Begbroke, UK, specializes in manufacturing advanced laser marking technology. This technology enables the creation of permanent, invisible structures such as serial numbers, images, and cryptographic data within transparent materials like diamonds, glass, polymers, and plastics without altering their surface or integrity. Opsydia's innovative solution aims to disrupt various industries by enhancing security, traceability, and authenticity in transparent materials.

Founded in 2011, PervasID specializes in developing wide area RFID systems that offer location capabilities based on the EPC Class1 Gen2 standard. The company's technology enables accurate tracking of goods and assets across various industries.

Crypto Quantique develops quantum-driven security solutions for connected devices by designing a secure chip on silicon that uses quantum processes to generate cryptographic keys. The chip can be integrated into new devices or retrofitted into existing ones, enabling multiple applications to operate with unique, unforgeable keys that do not need to be stored. The company combines cryptography and quantum physics in a platform that delivers hardware and software products for future-proof cybersecurity, with a focus on protecting local networks and IoT environments through end-to-end security in a scalable manner. Founded in 2015 and based in London, Crypto Quantique aims to provide robust protection for the Internet of Things by enabling on-demand cryptographic operations and key management.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.

Concr is a techbio company focused on enhancing cancer treatment through innovative predictive modeling. Utilizing methods derived from astrophysics, Concr aims to accurately forecast patient outcomes and responses to both novel and existing cancer therapies. The company's cloud-native platform, FarrSight®, enables researchers to simulate clinical trials, predict therapeutic responses, and conduct bioinformatics analyses, facilitating a more personalized approach to cancer care. By leveraging fragmented data from various stages of drug development, Concr eliminates the reliance on big data while generating precise multi-modal tumor models. Headquartered in London, with a subsidiary in Brisbane, Australia, Concr is backed by prominent investors, including the University of Cambridge Enterprise and Oncology Ventures, among others.

Ceryx Medical Limited is a biotechnology company based in Bath, United Kingdom, founded in 2016. The company specializes in developing and manufacturing innovative bio-electronic devices that utilize unique, patent-protected chip technology. These devices are designed to mimic Central Pattern Generators (CPGs), which are nerve centers in the body responsible for regulating various autonomic and rhythmical processes, including peristalsis, heart rate, and walking. Ceryx Medical aims to restore normal physiological functions that may be compromised due to disease or injury by employing artificial CPGs in their therapeutic devices.

GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.

NK:IO is a biotechnology company focused on developing natural killer cell-mediated immunotherapies for cancer. The company develops both cell therapies and small molecule therapeutics designed to target cancer and enhance the tumor-killing activity of natural killer cells.

Sano Genetics is a health technology company that operates a user-centered genetic data-sharing platform. The platform enables researchers to analyze data provided with user consent and to recruit for studies and clinical trials based on participants’ genetic and health information. It provides access to research on genetics and genetic diseases and supports programs that study the genetics of various human traits. The company connects individuals with researchers through its platform, supporting both common and rare disease research and enabling dynamic, health and genetic data sets to advance personalized medicine. Founded in 2017 and based in Cambridge, United Kingdom, Sano Genetics aims to empower participants to contribute their genetic and health data to scientific studies, facilitating collaboration and enabling new approaches to diagnosis and treatment.

SERG Technologies specializes in developing wearable technology designed for activity tracking, health monitoring, and gesture recognition. Their unique sensors enable users to control smart devices with subconscious movements, offering instant response times. Notably, SERG is dedicated to improving the lives of Parkinson's patients by creating tools that track symptoms, providing valuable insights for better treatment outcomes.

BibliU operates a digital platform that provides colleges and universities with managed access to millions of textbooks and academic resources. It offers automation tools, analytics, and offline support, enhancing student learning efficiency.

OW Smell Made Digital specializes in developing software and hardware solutions for controlling and integrating digital smell technology into various products, services, or content.

Semarion is a Cambridge-based company that combines microchip industry materials engineering with cell biology. It aims to revolutionize drug discovery by developing a platform that uses ultra-miniaturized, magnetically steerable wells for adherent cell screening.

Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.

Barocal develops innovative cooling technology designed to meet low-carbon refrigeration needs. Its proprietary materials undergo significant thermal changes under pressure application and removal, enhancing energy efficiency and eliminating greenhouse gas warming impact in commercial food and drink refrigeration.

Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.

Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, that specializes in developing tissue regenerative implants for knee cartilage injuries. Founded to commercialize technology from Oxford University, Orthox aims to transform the treatment of cartilage damage, addressing the needs of over 300 million patients worldwide affected by osteoarthritis. The company's flagship product, FibroFix, is a hydrogel implant designed to emulate human knee cartilage, enabling effective repair and regeneration of damaged tissues. Orthox offers several variations of FibroFix, including FibroFix Meniscus for meniscal cartilage repair and FibroFix Cartilage for articular cartilage damage. The implants promote integration with the body's cells, facilitating a return to active, pain-free living. With plans to expand its technology to other joints and additional applications beyond orthopaedics, Orthox is positioned to capitalize on the rapidly growing biomaterials market, projected to exceed $250 billion by 2025.

Sano Genetics is a health technology company that operates a user-centered genetic data-sharing platform. The platform enables researchers to analyze data provided with user consent and to recruit for studies and clinical trials based on participants’ genetic and health information. It provides access to research on genetics and genetic diseases and supports programs that study the genetics of various human traits. The company connects individuals with researchers through its platform, supporting both common and rare disease research and enabling dynamic, health and genetic data sets to advance personalized medicine. Founded in 2017 and based in Cambridge, United Kingdom, Sano Genetics aims to empower participants to contribute their genetic and health data to scientific studies, facilitating collaboration and enabling new approaches to diagnosis and treatment.

Paragraf is a UK-based company specializing in graphene technology. Established in 2015, it focuses on developing high-purity graphene products for commercial applications, particularly in electronics. The company produces graphene electronic devices and sensors using contamination-free technology.

Cambridge Touch Technologies develops piezoelectric-based 3D touch technology for smartphones, tablets, automotive, and industrial applications. Its UltraTouch platform combines proprietary artificial intelligence with sophisticated signal processing and a piezoelectric force film to deliver an all-in-one touch and force sensor architecture that offers advanced functionality at lower cost and scales to curved and foldable device sizes. The company targets pressure sensing and 3D touch to enhance interaction in consumer electronics and industrial applications.

DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.

Pathfinder Medical develops an electronic guidance system for minimally invasive vascular procedures. The platform provides image-guided needle targeting, real-time catheter navigation, and assistive guide-wire features to improve precision and reduce procedural risk in interventional radiology and vascular surgery. It enables clinicians to reach difficult blood vessels without open surgery and supports applications such as bypassing peripheral blockages and creating vascular access for dialysis.

Psyomics specializes in the development of proteomic diagnostics aimed at improving early diagnosis and treatment outcomes for individuals with neuropsychiatric disorders. The company offers web-based assessment triage designed to facilitate diagnostic and pathway prediction for mental health conditions. By integrating digital profiling with cutting-edge biological research, Psyomics enhances diagnostic accuracy and supports primary care practitioners in effectively managing their patients' mental health needs. This innovative approach digitally replicates a psychiatric assessment at the initial point of contact, thereby enabling patients to achieve better recovery outcomes from mental health disorders.

Fuel3D produces an affordable handheld 3D scanner that captures high‑resolution shape and color data in seconds. The device combines pre‑calibrated stereo cameras with photometric imaging, enabling rapid, accurate 3D modeling for applications such as gaming, animation, and product design. Developed by a team of engineers and scientists at Oxford University, the technology originated in medical imaging and has been adapted for broader creative and industrial use. Fuel3D offers a point‑and‑shoot system that is significantly cheaper than traditional scanners, making high‑quality 3D capture accessible to independent developers, designers, and artists. The company is led by CEO Stuart Mead, who brings experience from multiple successful technology ventures.

Brainomix develops AI-powered imaging biomarkers for neurological and cerebrovascular disorders. Its software suite, including e-ASPECTS, e-CTA, and e-Mismatch, automates brain scan analysis to assist physicians in making timely treatment decisions for stroke patients.

Founded in 2019, Wayland Additive specializes in developing, manufacturing, and distributing metal additive manufacturing 3D printing machines. The company serves industries such as aerospace and medical, offering advanced solutions like electron beam lithography.

Charco Neurotech is a medical technology company focused on creating non-invasive wearable devices aimed at enhancing the quality of life for individuals with Parkinson's disease. The company's primary innovation involves a wearable device that modulates sensory dysfunction, which aids users in improving their movement speed and overall mobility. By addressing specific challenges faced by those living with Parkinson's, Charco Neurotech seeks to empower individuals to maintain a more active and normal lifestyle.

Carbon Re is a climate technology company specializing in artificial intelligence for industrial decarbonization. It focuses on energy-intensive sectors like cement, steel, and glass, which contribute over 20% of global emissions. Carbon Re's Delta Zero platform uses deep learning to rapidly develop and deploy new low-carbon processes, designs, and materials.

Cheesecake Energy develops advanced thermal and compressed air energy systems to store renewable energy from intermittent sources, providing reliable power on demand.

PetMedix Ltd is a veterinary biopharmaceutical company based in Hinxton, United Kingdom, that specializes in therapeutic drug discovery for pets. Founded in 2017, the company utilizes advanced scientific techniques to develop innovative antibody therapies aimed at improving the health and well-being of companion animals. PetMedix has created specialized platforms, including the Ky9 and Felyne transgenic mouse systems, which are designed to produce therapeutic-quality antibodies tailored for pets. This approach allows for the generation of a diverse repertoire of antibodies that mirrors the immune systems of companion animals, enabling veterinarians to administer safe and effective monoclonal antibody treatments. By applying over thirty years of expertise in human drug development to veterinary medicine, PetMedix is dedicated to enhancing the quality of life for pets through cutting-edge therapies.

Helio Display Materials is a developer of innovative perovskite-based materials aimed at enhancing display technology. The company focuses on creating materials that enable brighter and more colorful displays while significantly reducing power consumption. By leveraging metal halide perovskites, which can be synthesized using low-temperature processes and earth-abundant precursor materials, Helio aims to produce vibrant and efficient light-emitting technologies for televisions and displays. The company emphasizes collaboration with scientific and industry experts to expedite research and development, ensuring a strong scientific foundation for its intellectual property. Helio's mission is to improve display performance and efficiency, ultimately providing a superior visual experience.

Nozzle.ai is an eCommerce and advertising optimization platform focused on enhancing sales for online sellers, particularly on Amazon. The company provides a suite of services, including marketplace audits, advertisement optimization, and consulting. Utilizing data science, Nozzle.ai analyzes customer buying patterns to deliver insights on key metrics such as customer repeat order rates, lifetime value, and customer acquisition costs. This data-driven approach enables online sellers and agencies to improve their advertising strategies, ultimately increasing sales and revenue. Founded in 2014 and headquartered in London, Nozzle.ai operates under the umbrella of Beeswax, Inc. after rebranding from MediaGamma Limited in May 2020. The company's offerings also include artificial intelligence consultancy, machine learning operations, and various support services for setting up and managing advertising campaigns.

Founded in 2020, Nyobolt is a UK-based company specializing in advanced battery technology for automotive applications. It focuses on developing high-power, fast-charging batteries with large energy storage capacity.

Echion Technologies, founded in 2017 and based in Cambridge, United Kingdom, specializes in developing advanced anode materials for lithium-ion (Li-ion) batteries. Their proprietary XNO® material offers faster charging times, longer lifespans, and improved safety compared to traditional options. The company targets the heavy-duty electric vehicle market, aiming to enhance efficiency and sustainability within the transportation sector by providing optimized power anode materials for cost-effective battery production.

Bonnet Ltd. is a London-based company established in 2019 that specializes in charging-as-a-service solutions for electric vehicle drivers. Its platform simplifies the charging experience by enabling users to access a wide network of public chargers through a single application, eliminating the need for separate registrations with individual charging networks. By streamlining the process, Bonnet aims to enhance convenience for both drivers and businesses, facilitating easier and more efficient electric vehicle charging.

Arkivum is a provider of long-term data preservation and archiving software and services. It offers cloud-based, on-premises and hybrid solutions that store, secure and manage encrypted data for the long term, ensuring data integrity and accessibility in regulated sectors. The company serves higher education, healthcare, life sciences, digital heritage, corporate archives, pharmaceuticals and financial services, and operates through a network of resellers and OEM partners. Arkivum emphasizes vendor-neutral technology with data ownership retained by clients and supports compliance with evolving regulatory requirements through its archiving and data lifecycle tools.

Fresh Check is a simple sticker that you put inside the packaging of food that changes colour when your food has actually gone off, not when the use-by date says so.

Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.

Porotech is a Cambridge University spin-out focused on developing wide-bandgap compound gallium nitride (GaN) semiconductors. It aims to revolutionize the electronics industry by applying advanced material technologies to unlock GaN's full potential, enabling more efficient light-emitting diodes and other electronic devices.

PredictImmune Ltd is a biotechnology company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. Established in 2017, the company offers PredictSURE IBD, a diagnostic tool designed to identify patients with Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, who are at risk of severe, relapsing disease. This simple lab test requires only a small blood sample and provides critical insights that enable healthcare providers to tailor early biologic therapies for at-risk patients. By delivering personalized treatment options, PredictImmune aims to improve disease management and clinical outcomes for individuals suffering from IBD, addressing an important need recognized by physicians, patients, and payors alike.

Versed AI is a technology company that specializes in supply chain intelligence, utilizing advanced natural language processing and machine learning techniques. The company develops a software-as-a-service platform that automatically extracts and visualizes supply chain data from various text documents, creating comprehensive supply chain maps. This enables organizations to monitor, manage, and mitigate potential risks within their supply chains by identifying buyer-supplier relationships and potential points of failure. Founded by Simon Baker and Fenelle Boyle, Versed AI's innovative approach helps businesses enhance their understanding of supply chain dynamics and improve their operational resilience.

Machine Discovery is a spin-out from the University of Oxford focused on commercializing advanced machine learning technology. The company has developed a simulation management platform that utilizes proprietary neural network technology to enhance the efficiency of compute-intensive tasks. This platform enables clients to conduct simulations with minimal data input while achieving a high level of accuracy, specifically 99.9% fidelity. By accelerating costly calculations, Machine Discovery provides valuable statistical insights that aid clients in speeding up their innovation processes, thus addressing critical demands in various sectors.

Mogrify develops proprietary platform technologies that enable direct cellular reprogramming. These platforms use big-data approaches to predict transcription factors and growth factors required for producing any target human cell type from any source human cell type. Mogrify applies these platforms to generate functional cell types for in vivo reprogramming therapies, focusing on ophthalmology, otology, metabolic diseases, and other degenerative conditions.

iKVA develops AI-powered knowledge management software that enhances decision-making and organizational efficiency. Its platform employs advanced vector mapping technology, dark data discovery, and multilingual information retrieval to help businesses uncover hidden insights, reduce costs, and boost productivity.

Zentraxa is a biotechnology company specializing in the design, production, and testing of innovative synthetic biopolymers. Utilizing its proprietary technology platform, Zentide, the company advances the capabilities of peptide synthesis by overcoming traditional bio-design limitations through a universal manufacturing process. Zentraxa's biopolymers are engineered to support diverse medical applications, including the development of biological adhesives. This unique approach allows clients to enhance their research and development efforts, positioning Zentraxa as a leader in the field of synthetic biopolymers.

Abselion specializes in the development of biological sensors aimed at the rapid and cost-effective detection of biological substances such as proteins, DNA, and small molecules. The company focuses on simplifying the analysis of these biomolecules for pharmaceutical research and manufacturing. Its diagnostic analyzers and kits facilitate the analysis of biomolecular interactions, including protein interaction analysis, enabling researchers to achieve sensitive and timely medical diagnoses. Through its innovative technology, Abselion enhances the efficiency of biomedical research and contributes to advancements in medical diagnostics.

Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.

Carbometrics is a specialist chemistry company focused on the design, synthesis and derivatisation of highly selective carbohydrate-binding molecules. Its technology centers on glucose-binding receptors developed for sensing applications, produced through a scalable synthesis that delivers robustness under demanding conditions. Building on more than 20 years of research from Professor Anthony Davis’s group at the University of Bristol, the company aims to realise a reliable glucose sensing platform for healthcare use, including continuous glucose monitoring. The approach seeks to enable accurate, robust detection of glucose in diverse environments, supporting the development of next-generation glucose sensors.

GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.

Riverlane is a developer of quantum computing software focused on transforming experimental technology into commercial products. The company engineers innovative instruments in collaboration with quantum computer manufacturers, addressing the need for new hardware and software tools to manage the instability of qubits and rectify system defects at unprecedented speeds. Riverlane's software includes an ultra-low latency quantum operating system that accelerates quantum-classical hybrid algorithms, supporting hardware research and development. Additionally, the company creates algorithms designed to optimize the use of the entire quantum computing stack, assisting hardware partners in minimizing the system errors that currently challenge quantum computing capabilities.

PhoreMost is a UK-based drug discovery company specializing in identifying new druggable targets for cancer and other diseases. Established in 2014, it develops Site-Seeker, a platform that systematically uncovers druggable sites in the human genome and links them to useful therapeutic functions in live cells.

Entia specializes in improving access to blood tests through innovative medical devices. Founded in 2014, it offers Aptus for haemoglobin and haematocrit testing, benefiting health screening, maternal care, nutrition, and sports fields. Additionally, Entia provides Affinity, enabling cancer patients to monitor their blood counts at home, reducing infection risks and hospital visits.

Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

TextMine is an AI-powered knowledge base that consolidates business-critical documents such as invoices, payslips, tender documents, compliance reports, and contracts into a single operational layer. This enables proactive decision-making, increases data transparency, and allows for more scalable and uniform document creation, ultimately helping organizations save time and money while reducing risk and enhancing compliance.